News

Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.

Certain healthcare use cases are ripe for AI, but still must provide a human touch to truly benefit patient experience. 

According to the new Rock Health funding report in Q1 digital health companies raised $3.1 billion in new investments. However, with the coronavirus hurting the economy, the rest of the year may not follow suit. 

Spearheaded by the Information & eGovernment Authority (iGA), the new wristbands are part of the government’s effort in quickly tracing new cases of COVID-19, as well as keeping track of active cases.

The company will use the money to increase its European presence.

The app requires no accessories or hardware other than the user’s smartphone.  

The new round was led by General Catalyst with participation from F-Prime Capital, Kickstart Seed Fund, Diōko Ventures and Jonathan Bush. 

The company is tripling its physician pool by the end of April, and has launched a new patient dashboard.

During a HIMSS20 webinar, Seattle Children's Hospital's Chief Data Officer Ryan Sousa explains the hospital's digital transformation. 

From 2000 to 2017, the number of registered clinical trials featuring CGMs, apps and other connected devices rose at a 34% CAGR, according to new data from Harvard researchers.